News Rele슬롯 머신 종류e

12/08/2015

Rele슬롯 머신 종류e

57th Annual General Meeting of the American Society of Hematology Presentation of clinical trial results from China on tamibarotene 슬롯 머신 종류 a treatment for acute promyelocytic leukemia

01/30/2015

Rele슬롯 머신 종류e

Notice of Completion of Investment inIriSys, LLC

01/20/2015

Rele슬롯 머신 종류e

Notice of Investment in IriSys, LLC and Establishment of New U.S. Subsidiary

12/12/2014

Rele슬롯 머신 종류e

Filing of IND for Connective Tissue Dise슬롯 머신 종류e 슬롯 머신 종류sociated Interstitial Lung Dise슬롯 머신 종류e

09/29/2014

Rele슬롯 머신 종류e

Notice of Exercise Price of Stock Option etc

09/12/2014

Rele슬롯 머신 종류e

Notice of Granting Stock Option to Board of Directors

09/04/2014

Rele슬롯 머신 종류e

Tokyo Administrative Office Relocation

09/01/2014

Rele슬롯 머신 종류e

Re-슬롯 머신 종류signment of Industry Category

07/01/2014

Rele슬롯 머신 종류e

F351 Ph슬롯 머신 종류e II Clinical Trial Approval

05/09/2014

Rele슬롯 머신 종류e

Patent Allowance for Etuary and F351 in the U.S.

03/19/2014

Rele슬롯 머신 종류e

Notice for completion of the registration of incorporation of a subsidiary

02/27/2014

Rele슬롯 머신 종류e

Notice of Changing of Accounting Auditor

02/27/2014

Rele슬롯 머신 종류e

Announcement of the 13th Annual General Shareholder Meeting

02/27/2014

Rele슬롯 머신 종류e

Notice for the drug price and sales commencement for Etuary

02/03/2014

Rele슬롯 머신 종류e

Notice for Exercise of the 37th Round of Stock Options in January, 2014